Two new vaccines against bluetongue recommended for approval
Submitted by Anonymous (not verified) on 17 January 2025 - 13:54
Two new vaccines against bluetongue recommended for approval
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025
Submitted by Anonymous (not verified) on 17 January 2025 - 13:54
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025
Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 17 January 2025 - 13:03
Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 11, Status: Authorised
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
Submitted by Anonymous (not verified) on 17 January 2025 - 10:58
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
PSUSA/00002843/202404
Submitted by Anonymous (not verified) on 17 January 2025 - 9:36
PSUSA/00002843/202404
Policy 83: Policy on visiting and collaborating experts involved in the activities of the European Medicines Agency
Submitted by Anonymous (not verified) on 17 January 2025 - 9:27
Policy 83: Policy on visiting and collaborating experts involved in the activities of the European Medicines Agency
PSUSA/00000936/202406
Submitted by Anonymous (not verified) on 16 January 2025 - 16:32
PSUSA/00000936/202406
PSUSA/00001382/202406
Submitted by Anonymous (not verified) on 16 January 2025 - 16:31
PSUSA/00001382/202406
PSUSA/00001737/202405
Submitted by Anonymous (not verified) on 16 January 2025 - 16:29
PSUSA/00001737/202405
PSUSA/00003136/202405
Submitted by Anonymous (not verified) on 16 January 2025 - 16:28
PSUSA/00003136/202405